The Library
Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer : the MRC STAMPEDE trial
Tools
Sydes, Matthew R., Parmar, Mahesh K. B., James, Nicholas D., Clarke, Noel W., Dearnaley, David P., Mason, Malcolm D., Morgan, Rachel C., Sanders, Karen and Royston, Patrick (2009) Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer : the MRC STAMPEDE trial. Trials, 10 (1). 39. doi:10.1186/1745-6215-10-39 ISSN 1745-6215.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1186/1745-6215-10-39
Abstract
Background:
The multi-arm multi-stage (MAMS) trial is a new paradigm for conducting randomised controlled trials that allows the simultaneous assessment of a number of research treatments against a single control arm. MAMS trials provide earlier answers and are potentially more cost-effective than a series of traditionally designed trials. Prostate cancer is the most common tumour in men and there is a need to improve outcomes for men with hormone-sensitive, advanced disease as quickly as possible. The MAMS design will potentially facilitate evaluation and testing of new therapies in this and other diseases.
Methods:
STAMPEDE is an open-label, 5-stage, 6-arm randomised controlled trial using MAMS methodology for men with prostate cancer. It is the first trial of this design to use multiple arms and stages synchronously.
Results:
The practical and statistical issues faced by STAMPEDE in implementing MAMS methodology are discussed and contrasted with those for traditional trials. These issues include the choice of intermediate and final outcome measures, sample size calculations and the impact of varying the assumptions, the process for moving between trial stages, stopping accrual to each trial arm and overall, and issues around perceived trial complexity.
Conclusion:
It is possible to use the MAMS design to initiate and undertake large scale cancer trials. The results from STAMPEDE will not be known for some years but the lessons learned from running a MAMS trial are shared in the hope that other researchers will use this exciting and efficient method to perform further randomised controlled trials.
Item Type: | Journal Article | ||||
---|---|---|---|---|---|
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences > Cancer Research Unit Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||
Journal or Publication Title: | Trials | ||||
Publisher: | Biomed Central | ||||
ISSN: | 1745-6215 | ||||
Official Date: | 2009 | ||||
Dates: |
|
||||
Volume: | 10 | ||||
Number: | 1 | ||||
Article Number: | 39 | ||||
DOI: | 10.1186/1745-6215-10-39 | ||||
Status: | Peer Reviewed | ||||
Publication Status: | Published | ||||
Access rights to Published version: | Open Access (Creative Commons) |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |